Untreated Tardive Dyskinesia Hinders Use of Antipsychotics
Jul 29, 2024 · Tardive dyskinesia, often underdiagnosed and undertreated, hinders patient adherence to antipsychotics, affecting mental health treatment and caregivers' well …
Metoclopramide in the Treatment of Diabetic Gastroparesis
Acute Dystonic Reactions Acute dystonic reactions are the most frequent extrapyramidal side effects (EPS) from metoclopramide and typically occur within 24–48 h of initiating treatment, …
LAIs Tied to Lower Relapse, Mortality Risk in Schizophrenia
Oct 16, 2025 · Long-acting injectable antipsychotics are linked to a lower risk for disease relapse and mortality than oral antipsychotics in adults with schizophrenia, a new study shows.
Forget the Tremor: These Symptoms Come First in Parkinson’s
Jun 10, 2025 · It often appears alongside other signs like a softer, monotone voice or reduced arm swing while walking — both early signs of extrapyramidal dysfunction.
Olanzapine Associated With Lower Rate of Extrapyramidal
Oct. 2, 2003 — Olanzapine was associated with the fewest patients with extrapyramidal symptoms (EPS) at six months compared with baseline, according to the results of a large …
Treatment Considerations for Psychiatric Syndromes Associated …
Another important consideration is HIV-infected patients' increased sensitivity to antipsychotic-induced extrapyramidal symptoms, thought to be related to the damage to basal ganglia …
'Impressive' New Data on Novel Schizophrenia Hopeful KarXT
May 8, 2024 · The novel investigational antipsychotic KarXT was effective and well tolerated in adults with schizophrenia experiencing acute psychosis in a second phase 3 trial.
Ending Long-term Anticholinergic Use: It Can Be Done - Medscape
Jun 3, 2020 · Ending the common, but unsanctioned, practice of long-term anticholinergic use to head off extrapyramidal symptoms (EPS) associated with antipsychotic medications in patients …
New Guidance on Antipsychotic Choice - Medscape
Jul 19, 2019 · In general, older antipsychotics were more frequently associated with extrapyramidal motor side effects (EPS) and elevations in prolactin levels. Many newer …
Positive Phase 3 Results for Antipsychotic in Schizophrenia
Jan 12, 2024 · The investigational antipsychotic KarXT is effective in reducing positive and negative symptoms of schizophrenia, with a favorable side-effect profile in the pivotal …